Straumann Holding Ag · SIX:STMN

Straumann — Q1 2014 Earnings Presentation

13 slides from Straumann's earnings presentation, Apr 30, 2014

  1. Slide 1: 2014 First-quarter revenue Conference Call

    29.04.2014 2014 First-quarter revenue Conference Call Basel, 30 April 2014 Disclaimer This presentation contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and other factors that may cause act

  2. Slide 2: 2014 YTD Highlights

    29.04.2014 2014 YTD Highlights Marco Gadola, CEO Promising start to 2014; strongest quarter in three years REVENUE GROWTH1 MAIN CONTRIBUTOR CHF 180m +6% Europe Performance reflects investments in Strongest quarter in 3 years. Return to growth after 2 years of growth markets, new products Continued i

  3. Slide 3: Highly successful ITI World Symposium

    29.04.2014 Highly successful ITI World Symposium – platform to promote new research and solutions  Leading academic event in oral implantology  ~4200 participants  Straumann Corporate Forum attended by >2000 dental professionals  Special promotions offered 5 Regional and business review Thomas D

  4. Slide 4: Good growth across all regions

    29.04.2014 4 consecutive quarters of solid growth 10% 8% 6% 4% 2% 0% -2% -4% -6% -8% -10% -12% Market for tooth replacement & restoration (leading implant companies) Straumann l.c. growth Straumann, Nobel Biocare, Zimmer Dental, Biomet 3i, Dentsply Implants - based on company and SEC reports 7 as we

  5. Slide 5: Europe & N. America – main growth contributors

    29.04.2014 Europe & N. America – main growth contributors Revenue change (organic)  Return to growth in nearly all 4.1% European countries Europe 0.2% 56%  New implant price structure; (1.4%) customers upgrade to premium (3.4%) Roxolid implants (7.7%)  Spain and Nordics deliver 57% strongest perf

  6. Slide 6: Solid growth in implants and prosthetics

    29.04.2014 Solid growth in implants and prosthetics Implants Restorative Regeneratives 11 Good strategic progress Marco Gadola, CEO 6

  7. Slide 7: Investment in MegaGen to drive expansion in value implant segment in Asia

    29.04.2014 Investment in MegaGen to drive expansion in value implant segment in Asia  Founded in 2002, MegaGen is one of Korea’s fastest-growing dental implant companies  Straumann purchases 3%-interest-bearing convertible bonds for a total of CHF 27 million  Capital injection will accelerate Meg

  8. Slide 8: A combination to eclipse the market leader

    29.04.2014 A combination to eclipse the market leader Straumann botiss Geistlich Bone allografts * Bone xenografts Bone synthetic grafts Bone blocks Custom bone blocks Bone rings Collagen cones Fleeces & sponges Membranes Soft-tissue grafts Biologics 15 *US only Separate-brand strategy to address pr

  9. Slide 9: 2014 outlook helped by an exciting roll-out program

    29.04.2014 2014 outlook helped by an exciting roll-out program New prosthetic components for fixed full-arch restorations launched at ITI congress  Enhanced screw-retained prosthetic solution especially for edentulous patients  New range of screw-retained implant abutments offering increased flexi

  10. Slide 10: Outlook for 2014 unchanged

    29.04.2014 Value-adding solutions to meet clinician and patient needs abutments Ceramic New SR implant High Ceramic implants Smaller, less Fixed Level of sophistication invasive implants immediate edentulous solutions Implants for Straumann Roxolid Variobase narrow spaces Esthetic, fast implant Cost

  11. Slide 11: Questions & Answers; Calendar of upcoming events

    29.04.2014 Questions & Answers 21 Calendar of upcoming events 2014 30 April First quarter sales Audio webcast 05 May Investor meetings Milano 06 May Investor meetings Munich 11-12 June Vontobel Swiss Conference Interlaken/CH 13 June Deutsche Bank Swiss & German Conference Berlin 26 August Half-year

  12. Slide 12: Straumann's currency exposure

    29.04.2014 Straumann’s currency exposure Revenue breakdown 2013 Other 20% Average exchange rates (rounded) FX sensitivity (+/- 10%) on... EUR FY 2013 YTD 2014 Revenue EBIT 40% EURCHF 1.23 1.23 +/- 25 million +/- 15 million USD / CAD / USDCHF 0.93 0.90 +/- 17 million +/- 7 million AUD 28% JPYCHF 0.95

  13. Slide 13: International Headquarters

    29.04.2014 International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone +41(0)61 965 11 11 Fax +41(0)61 965 10 01 www.straumann.com 13

Straumann Group — Q1 2014 Earnings Presentation on 6ix